Gallbladder cancer: a morphological and molecular update

Area of Science:

• Gastroenterology
• Oncology
• Pathology

Background:

• Gallbladder cancer (GBC) exhibits significant geographical incidence variations, notably high in India and Chile compared to Western countries.
• Key risk factors include gallstones, infections, and anomalous pancreatobiliary ductal junction.
• GBC development follows two main pathways: metaplasia/dysplasia or pre-existing adenoma, with the former being more common and often lacking macroscopic signs.

Purpose of the Study:

• To summarize the understanding of gallbladder cancer (GBC) epidemiology, risk factors, and molecular pathology.
• To highlight the importance of microscopic examination and accurate staging for GBC diagnosis and patient management.
• To review genetic alterations associated with GBC development, risk factors, and prognosis.

Main Methods:

• Review of epidemiological data on GBC incidence.
• Analysis of identified risk factors and pathological pathways.
• Examination of genetic alterations in preinvasive and invasive GBC stages.
• Correlation of genetic changes with specific risk factors and prognostic indicators.

Main Results:

• Geographical variations in GBC incidence are significant, with specific high-risk regions identified.
• Anomalous pancreatobiliary ductal junction is linked to increased K-ras mutations.
• Prognostic indicators include differential expression of p21, p27, and c-erb-B2.
• Clinical, imaging, and other factors are being investigated for early GBC risk identification.

Conclusions:

• Gallbladder cancer (GBC) is a significant public health issue, particularly in high-incidence areas.
• Understanding risk factors and molecular pathways is essential for early detection and improved patient outcomes.
• Microscopic evaluation and comprehensive staging are critical for effective GBC management.